Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

News Conference News TCT 2015

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Yael L. Maxwell

October 16, 2015

Presentation TCT 2015

Hyperlipidemic Therapy: From Statins to PCSK9 Inhibitors

Presenter: George D. Dangas, Paul A. Gurbel, Joshua W. Knowles

October 13, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

News Conference News TCT 2013

Misperceptions Persist Regarding ‘Inappropriate’ PCI

October 30, 2013

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Conference News TCT 2012

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

October 24, 2012

Presentation TCT 2012

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Presenter: Pedro Moreno

October 23, 2012

News Conference News

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

November 21, 2011

News Conference News

Coronary Heart Disease Mortality Down, But Prevention Efforts Still Needed

November 08, 2011

Advertisement

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Hyperlipidemic Therapy: From Statins to PCSK9 Inhibitors

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Misperceptions Persist Regarding ‘Inappropriate’ PCI

Stroke Prevention Strategies Discussed

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

Coronary Heart Disease Mortality Down, But Prevention Efforts Still Needed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content